Truveta
Saving lives with data by providing regulatory-grade safety and effectiveness data.
Health
Paid
View Pricing
Real-World Data Analysis
Health Economics and Outcomes Research
Clinical Trial Optimization
Guardant Health
4.6
Paid Guardant Health is highly regarded for its innovative liquid biopsy technology, providing actionable insights for personalized cancer care.
Conquering cancer with data through the power of blood tests, enabling early detection and personalized treatment.
0 views
0 saves
|
Refined 2/22/2026
About Guardant Health
Guardant Health focuses on precision oncology through blood-based liquid biopsies. Their technology analyzes circulating tumor DNA (ctDNA) to provide insights across all stages of cancer, from early detection to treatment monitoring. The core architecture involves advanced sequencing and data analysis pipelines, identifying biomarkers and genomic alterations. The Guardant360® CDx test, for instance, is FDA-approved as a companion diagnostic. Their solutions offer value by informing treatment decisions, assessing treatment response, and detecting minimal residual disease (MRD). Use cases include identifying patients who might benefit from specific therapies, monitoring disease progression, and detecting recurrence earlier than traditional methods. They use machine learning algorithms to improve the sensitivity and specificity of cancer detection, leading to better clinical outcomes and more personalized cancer care.
Core Capabilities
Guardant Health focuses on precision oncology through blood-based liquid biopsies.
Main Tasks
MRD Assessment
Explore all tools that specialize in mrd assessment. This domain focus ensures Guardant Health delivers optimized results for this specific requirement.
